The benefits from 10 years of measles immunization in the United States.
作者信息
Witte J J, Axnick N W
出版信息
Public Health Rep. 1975 May-Jun;90(3):205-7.
Abstract
摘要
相似文献
1
The benefits from 10 years of measles immunization in the United States.美国十年麻疹免疫接种的益处。
Public Health Rep. 1975 May-Jun;90(3):205-7.
2
Health impact of measles vaccination in the United States.美国麻疹疫苗接种对健康的影响。
Pediatrics. 1985 Oct;76(4):524-32.
3
[Measles vaccination].[麻疹疫苗接种]
Zentralbl Bakteriol Orig A. 1972 May;220(1):273-83.
4
Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.2001年美国7种儿童常规免疫接种疫苗时间表的经济学评估
Arch Pediatr Adolesc Med. 2005 Dec;159(12):1136-44. doi: 10.1001/archpedi.159.12.1136.
5
Priority for measles vaccine.麻疹疫苗的优先级。
Indian Pediatr. 1973 Feb;10(2):57-8.
6
[Measles vaccination (2): attenuated vaccine is preferable].
Lakartidningen. 1968 Dec 4;65(49):4905-9.
7
Population immunity to measles in the United States, 1999.1999年美国麻疹的群体免疫力
J Infect Dis. 2004 May 1;189 Suppl 1:S91-7. doi: 10.1086/377713.
8
Measles and measles vaccine in pre-industrial countries.
Mod Trends Med Virol. 1967;1(0):141-61.
9
[Single or double dose of vaccine needed for the eradication of measles in Spain?].
An Esp Pediatr. 1993 Feb;38(2):130-4.
10
Evaluating the benefits of increasing measles immunization rates.评估提高麻疹免疫接种率的益处。
Health Serv Res. 2001 Oct;36(5):885-909.
引用本文的文献
1
Measles and rubella: From global health challenges to advancements in molecular diagnostics in the elimination era.
Mol Ther Nucleic Acids. 2025 Sep 2;36(4):102698. doi: 10.1016/j.omtn.2025.102698. eCollection 2025 Dec 9.
2
From jurisdiction to veridiction: Expertise and economization of immunization policy in the United States.从管辖权到裁决权：美国免疫政策的专业知识与节约化
Econ Soc. 2025 Jun 26;54(2):310-333. doi: 10.1080/03085147.2025.2517951. eCollection 2025.
3
Costs related to immunopreventable diseases: Brazil and its geographic areas (immunopreventable diseases' costs in Brazil).与免疫预防疾病相关的成本：巴西及其地理区域（巴西免疫预防疾病的成本）。
BMC Health Serv Res. 2021 Oct 27;21(1):1165. doi: 10.1186/s12913-021-07117-5.
4
Measles control in developing and developed countries: the case for a two-dose policy.发展中国家和发达国家的麻疹控制：两剂次政策的情况
Bull World Health Organ. 1993;71(1):93-103.
5
Assessing prevention effectiveness using data to drive program decisions.利用数据评估预防效果，以推动项目决策。
Public Health Rep. 1994 Mar-Apr;109(2):187-94.
6
Low measles incidence: association with enforcement of school immunization laws.低麻疹发病率：与学校免疫法的实施相关联
Am J Public Health. 1981 Mar;71(3):270-4. doi: 10.2105/ajph.71.3.270.
7
Epidemiological models of poliomyelitis and measles and their application in the planning of immunization programmes.脊髓灰质炎和麻疹的流行病学模型及其在免疫规划中的应用。
Bull World Health Organ. 1982;60(3):405-22.
8
Measles eradication policies.麻疹根除政策。
Br Med J (Clin Res Ed). 1982 Apr 3;284(6321):997-8. doi: 10.1136/bmj.284.6321.997.
9
Cost-benefit analysis and immunization programmes in developing countries.发展中国家的成本效益分析与免疫规划
Bull World Health Organ. 1980;58(3):491-7.
10
Immunisation practice and policy.免疫接种实践与政策。
J Epidemiol Community Health. 1984 Dec;38(4):265-9. doi: 10.1136/jech.38.4.265.
本文引用的文献
1
Benefits due to immunization against measles.麻疹免疫带来的益处。
Public Health Rep (1896). 1969 Aug;84(8):673-80.
2
Progress of measles eradication in the United States.美国麻疹根除工作的进展
Public Health Rep (1896). 1968 Mar;83(3):245-8.
3
Epidemiologic basis for eradication of measles in 1967.
Public Health Rep (1896). 1967 Mar;82(3):253-6.
Zotero 插件